Drug Pipeline

PRL3-ZUMAB Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07290088 Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients Advanced Solid Cancers Recruiting
Phase 2
NCT04452955 A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors Solid Tumor Active, Not Recruiting
NCT07541001 PRL3-Zumab in Patients With Advanced Solid Tumors Advanced Malignant Solid Tumor Active, Not Recruiting
Phase 1/2
NCT07547228 A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD) Neovascular Age Related Macular Degeneration Recruiting
Sponsors Running PRL3-ZUMAB Trials
Get alerts when PRL3-ZUMAB trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free